Marquette Asset Management »

Aclaris Therapeutics shares owned by Marquette Asset Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Marquette Asset Management from 13F filings

Historical chart of Marquette Asset Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Marquette Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Marquette Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $97k 84k 1.15
2024-06-30 $92k 84k 1.10
2024-03-31 $104k 84k 1.24

More positions owned by Marquette Asset Management

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr Rus 1000 Grw Etf (IWF)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Mid Cap Etf (VO)
Victory Portfolios Ii Short Trm Bd Etf (USTB)
Invesco Exchange Traded Fd T S&p500 Pur Gwt (RPG)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
J P Morgan Exchange Traded F Equity Premium (JEPI)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Ishares Tr Rus 1000 Val Etf (IWD)

View all positions for Marquette Asset Management

Top funds holding Aclaris Therapeutics

BML Capital Management
Vanguard Group
D. E. Shaw & Co
Rock Springs Capital Management
Stonepine Capital Management
Acadian Asset Management
BlackRock
Trium Capital
BlackRock
Two Sigma Advisers
Renaissance Technologies
Two Sigma Investments
Aldebaran Capital
Bain Capital Life Sciences Investors
Qube Research & Technologies

View all funds holding Aclaris Therapeutics